AAVrh10-PCCA Gene Therapy Trial for Propionic Acidemia Initiated
A clinical trial is underway to assess the safety and efficacy of AAVrh10-PCCA gene therapy for propionic acidemia.
Company
Pharmaceutical intelligence for AAVrh10-PCCA with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.